Reza Kazemipour

Our mission is to accelerate the discovery of new medicines with physiologically-relevant, structured human cells that improve cell-based assay outcomes. We develop and scalably manufacture human induced pluripotent stem (iPS) cell-derived cardiac and neural platforms for drug discovery and development. Predictive, accurate, and consistent, our human models enable scientists to quickly and economically conduct research with improved outcomes in a simplified workflow. We also collaborate with drug discovery organizations to test their compounds with our in-house screening capabilities, create new cell-based models, and operationalize their human iPS cells at large scale for high throughput screening. StemoniX microHeart® products in high density plate formats provide researchers with structurally aligned cardiac cells resembling native human heart tissue with accelerated features of cell maturity. StemoniX microBrain® products in high density formats are physiologically relevant with biology, activity, functional maturity that mimic native human brain tissue. Available pre-plated to simplify your workflow, microHeart and microBrain are delivered in ambient conditions and ready for assay use soon after delivery. With leading-edge iPSC technologies, we are helping global institutions bring the most promising medicines to patients. Contact us at info@stemonix.com to discuss how StemoniX products and services can accelerate your discoveries.

ThingLogix is a provider of Internet of Things (IoT) solutions, solution components, development services, and advisory services. We offer Foundry, a proprietary cloud platform architected on Amazon Web Services (AWS), and Foundry Packages, a series of related component applications, to enable IoT solutions for multiple industries and use cases. Our technology enables sophisticated functionality, rapid time-to-market, simplified solution evolution over time, and extreme cost efficiency. ThingLogix is a certified AWS Advanced Technology Partner. We operate globally from our offices in San Francisco and Dubai.

Hyperloop Transportation Technologies Inc. (HyperloopTT) is an innovative transportation and technology company focused on realizing the Hyperloop, a system that moves people and goods at unprecedented speeds safely, efficiently, and sustainably. Through the use of unique, patented technology and an advanced business model of lean collaboration, open innovation and integrated partnership, HyperloopTT is creating and licensing technologies. Founded in 2013, HyperloopTT is a global team comprised of more than 800 engineers, creatives and technologists in 52 multidisciplinary teams, with 40 corporate and university partners. Headquartered in Los Angeles, CA, HyperloopTT has offices in Europe and the Middle East.

The company was founded in early 2012 as "Optimized Athlete"​ by Olympic athlete and World Record Holder Sky Christopherson to support the US women's cycling team prior to the 2012 Olympic Games. The underfunded team had become America's hope for a cycling medal when the Lance Armstrong drug scandal, termed 'The Greatest Fraud in American Sports'​, resulted in unexpected withdrawals of top U.S. men's professional cyclists due to performance enhancing drug use. To attempt a new model of drug-free training prior to the 2012 Olympic Games, over a dozen thought leaders in fields of sport, medicine, and technology were assembled into a think-tank 'Dream Team'​. OAthlete developed the first software platform to utilize a consumer digital health and wireless sensor ecosystem for Olympic training that included sleep data, nutrition data (including the first use of continuous blood sugar tracking) genetics, environment, psychology, and other physiology. The underdog women's team would go on to shock the world with a Silver Medal win in London. Their Olympic journey and inception of OAthlete is the subject of a feature-length documentary film called 'Personal Gold'​ (2016) acquired by Netflix and distributed world-wide. Now Personal GOLD, Inc, it is expanding it's technology ecosystem to develop software products for broader applications in health and fitness markets, starting with 'The Gold App'​ led by a world-class management, marketing, and advisory team. The company will continue work with Olympic athletes under it's USA2024 initiative to inform product development and provide inpirational marketing narratives. This ethos serves the vision of helping individuals to reach their potential using Data not Drugs®

Get high-converting, meeting-ready leads, powered by AI Want to close more deals, faster? It’s within reach with Vendisys. Our AI-powered prospecting engine, Converna®, precisely identifies and engages the people you’re looking for: the right decision makers at the right companies. Then it converts them into Powerful Actionable Leads (PALs®) and delivers them right to your inbox or CRM. So all you have to do is close the deal – and watch your sales and revenue grow! • Boost your lead conversions by 2-10X • Accelerate time-to-market by 2–5X • Earn ROI of 5–30X Artificial intelligence drives real results: “Vendisys helped us improve our time-to-meeting by over 200%. It’s amazing that with only one email [from Converna], we can have the CEO of Time Warner ask the CIO to refer us to the appropriate person.” Sacha Stel, Director of Sales, SoftSol Group “Vendisys has generated over 80% of the meeting activity for my region over the past nine months.” Jeff T. Wagner, Director of Sales, Hexis Cyber Solutions “The quality we have seen with Vendisys is unmatched. They are dedicated to the success of their clients, and it shows.” Peter Schumacher, Director of Marketing, BeyondTrust “Vendisys’ efforts allowed us to rapidly increase our footprint and visibility in the market while also expanding our pipeline by 35%.” Ediz Ertekin, VP of Field Operations, SnapLogic, Inc. Ready to meet your PALs? Schedule a demo at info@vendisys.com or visit our website, www.vendisys.com, for more information. Specialties B2B Lead Generation, Meeting-ready leads, Business Development, AI-powered solution, Pipeline Creation, and Demand Generation

L37 is a new generation, hybrid venture capital and private equity investment firm. The firm works alongside executive and founding teams leveraging frameworks, capital, and talent to engineer global opportunities and impact at scale.

Our mission is to accelerate the discovery of new medicines with physiologically-relevant, structured human cells that improve cell-based assay outcomes. We develop and scalably manufacture human induced pluripotent stem (iPS) cell-derived cardiac and neural platforms for drug discovery and development. Predictive, accurate, and consistent, our human models enable scientists to quickly and economically conduct research with improved outcomes in a simplified workflow. We also collaborate with drug discovery organizations to test their compounds with our in-house screening capabilities, create new cell-based models, and operationalize their human iPS cells at large scale for high throughput screening. StemoniX microHeart® products in high density plate formats provide researchers with structurally aligned cardiac cells resembling native human heart tissue with accelerated features of cell maturity. StemoniX microBrain® products in high density formats are physiologically relevant with biology, activity, functional maturity that mimic native human brain tissue. Available pre-plated to simplify your workflow, microHeart and microBrain are delivered in ambient conditions and ready for assay use soon after delivery. With leading-edge iPSC technologies, we are helping global institutions bring the most promising medicines to patients. Contact us at info@stemonix.com to discuss how StemoniX products and services can accelerate your discoveries.

Relay Ventures is an early stage venture capital firm that invests in passionate entrepreneurs disrupting and creating new markets through mobile technologies. Unlike other funds, Relay exclusively focuses on software for mobile devices and the connected Internet, creating an unparalleled set of networks and resources that tangibly help founders build world-class companies. With offices in Toronto and Calgary, the firm is active throughout North America. For additional information, visit www.relayventures.com.